Fusion event
HBV-ADAMTS19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGGGCCATCAGCGCATGCGTGGAACCTTT| |TCGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACATTATCGGGACTGATAACTCTGTTGTCC
End
128836155/129500462 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/103315; hsa-mir-103a-1/Downstream/2717387;
Upstream sequence
CTTTATTTATGGAGCTAGCATTTGAACAGGCCTCGCACCCTCCCTGGGCTGTCACGCTCGCTGGAGGTTAGCCTCGTCTTGTAAATACTTAGGATTACAG
Downstream sequence
ctcagtctctggggatctcagtcttttcctgtgaggatggtgaattcatcttctcaggtagtcacttgcaacgcctgccttagtctttgggtatctgttg
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.